Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03653416 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
NCT03653416 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 99 participants.
The verdict
NCT03653416, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
Study Summary
Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by 2030.
Interventions
- DRUG Bupivacaine
- DEVICE Ipack
- PROCEDURE Peri Articular Infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03653416
The ClinicalTrials.gov registry entry for NCT03653416 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT03653416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03653416 about?
NCT03653416 is a clinical study titled "Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty". Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by 2030.
What is the current status of trial NCT03653416?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2018-03-01. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03653416?
The interventions under investigation include: Bupivacaine (DRUG), Ipack (DEVICE), Peri Articular Infiltration (PROCEDURE).
Who is sponsoring clinical trial NCT03653416?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.